Cite
NAT2 and CYP2 E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
MLA
An, Hui-Ru, et al. “NAT2 and CYP2 E1 Polymorphisms Associated with Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients.” Clinical & Experimental Pharmacology & Physiology, vol. 39, no. 6, June 2012, pp. 535–43. EBSCOhost, https://doi.org/10.1111/j.1440-1681.2012.05713.x.
APA
An, H.-R., Wu, X.-Q., Wang, Z.-Y., Zhang, J.-X., & Liang, Y. (2012). NAT2 and CYP2 E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients. Clinical & Experimental Pharmacology & Physiology, 39(6), 535–543. https://doi.org/10.1111/j.1440-1681.2012.05713.x
Chicago
An, Hui-Ru, Xue-Qiong Wu, Zhong-Yuan Wang, Jun-Xian Zhang, and Yan Liang. 2012. “NAT2 and CYP2 E1 Polymorphisms Associated with Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients.” Clinical & Experimental Pharmacology & Physiology 39 (6): 535–43. doi:10.1111/j.1440-1681.2012.05713.x.